Clinical Trials in Houston

Showing 12201-12220 of 15,366 trials

Initiation of Oral Feeding at 30 Versus 33 Weeks Postmenstrual Age

NCT01787019

The purpose of the study is to determine if earlier initiation of oral (by mouth as opposed to tube) feedings in premature infants results in earlier attainment of full oral feedings and/or discharge.

Prematurity

The University of Texas Health Science Center, Houston66 participantsStarted Jan 2013

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Late Chronic Phase Chronic Myelogenous Leukemia

NCT01092741

Objectives: Primary endpoints: To achieve low levels of Polymerase Chain Reaction (PCR) ratios of B-cell antigen receptor (Bcr-Abl)/Bcr (molecular CR) in a significant proportion of patients after 12 months of higher doses (800 mg daily) of Gleevec therapy To increase the proportion of patients achieving a complete cytogenetic response in patients with Ph-positive chronic phase CML using initial higher dose Gleevec therapy. Secondary endpoints: To evaluate the durations of PCR negativity, cytogenetic response, hematologic control, and survival. To analyze differences in response rates and in prognosis within different risk groups and patient characteristics

Leukemia

M.D. Anderson Cancer Center47 participantsStarted Jul 2001

Houston, Texas, United States

COMPLETEDPhase 1/2< 1 mile

Oral Nadolol for the Treatment of Adults With Mild Asthma

NCT00670267

The purpose of this study is to confirm previous observations in asthmatics that chronic nadolol treatment reduces asthmatic airway hyper-responsiveness.

Asthma

Invion, Inc.10 participantsStarted Jan 2007

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

NCT00050531

The goal of this clinical research study is to learn if giving PEG-Alpha Interferon (PEG-Intron) and Sargramostim (GM-CSF) to patients receiving treatment with high dose Gleevec (imatinib mesylate) is more effective in treating CML in chronic phase than therapy with imatinib mesylate alone.

Leukemia, Myeloid, Chronic

M.D. Anderson Cancer Center94 participantsStarted Apr 2003

Houston, Texas, United States

Initiation of Oral Feeding at 30 Versus 33 Weeks Postmenstrual Age

Late Chronic Phase Chronic Myelogenous Leukemia

Oral Nadolol for the Treatment of Adults With Mild Asthma

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Find Trials by Condition in Houston

Strattice in Repair of Inguinal Hernias

Spectroscopy Versus Standard Care in Cervical Cancer Patients

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

Ticagrelor vs. Prasugrel Effects on Infarct Size

Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer

Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions

Study of Electrical Impedance Myography (EIM) in ALS